DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ratziu V, Rinella ME, Neuschwander-Tetri BA. et al.
EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study.
J Hepatol 2022;
76 (03) 506-517
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.